The Pfe machine is going to get a monster head start with Crizotinib. At this pace, 113 is going to have to 10x better (as the Harv has claimed) to catch up. If they could get the friggin trial started already, this company will be in everyone's cross hairs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.